Tempus AI, Inc.

TEM Healthcare Health Information Services

Tempus AI, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 83.4% from fiscal 2024.

Revenue
+23.1%
EPS
+82.2%
Free cash flow
+95.7%
Total debt
+8.44%

Quarter to September 2026, against a year earlier

75.66 5.23 +7.43%
Market cap
$12.9B
P/E
0.0×
Fwd P/E
−51.8×
Dividend yield
—
F-score
4/9
Altman Z
2.60
Beneish M
−1.25
Dividend safety
n/a

Tempus AI, Inc. (TEM) SEC filings, changes and red flags

Red flags

No red flags have been raised by Tempus AI, Inc.’s filings on file.

Filings

Form Period Filed What it reports Flags
10-Q Sep 30, 2026 P1I2: 5 added · 3 removed · 46 modified
P2I1A: no changes
8-K Nov 2, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Oct 23, 2026 8.01 Other events
10-Q Jun 30, 2026 P1I2: 35 added · 5 removed · 62 modified
P2I1A: 42 added · 1 modified
8-K Jul 30, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Jul 20, 2026 1.01 Entry into a material definitive agreement; 9.01 Financial statements and exhibits
8-K Jul 20, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K May 21, 2026 5.07 Submission of matters to a vote of security holders
8-K May 7, 2026 1.01 Entry into a material definitive agreement; 1.02 Termination of a material definitive agreement; 2.03 Creation of a direct financial obligation; 3.02 Unregistered sales of equity securities; 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Mar 31, 2026
8-K May 5, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-K Dec 31, 2025 1: 23 added · 12 removed · 110 modified
1A: 38 added · 31 removed · 200 modified
7: 48 added · 34 removed · 50 modified
8-K Feb 24, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Jan 11, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Sep 30, 2025
8-K Nov 4, 2025 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Aug 27, 2025 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Jun 30, 2025
8-K Aug 8, 2025 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Mar 31, 2025
8-K May 6, 2025 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-K Dec 31, 2024
8-K Feb 24, 2025 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Jan 13, 2025 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Sep 30, 2024
8-K Nov 4, 2024 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Jun 30, 2024
8-K Aug 6, 2024 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.